{"transactions":[{"id":4619388,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":600,"price":145.29,"value":87174.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":116684,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4619387,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":800,"price":144.4569,"value":115565.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $144.26 to $144.775.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":117284,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4619386,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":143.6917,"value":229906.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":118084,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4616425,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25054,"derivative":{"underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":4616424,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1347,"price":144.81,"value":195059.07,"ownership":{"direct":true},"balance_after":119684,"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":4616423,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":121031,"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":306125,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":1890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":69960,"derivative":{"exercise_price":72.34,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":1890},"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306124,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":23110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":23110},"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306123,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":11470,"price":138.0353,"value":1583264.891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":118234,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306122,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":16530,"price":137.365,"value":2270643.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":129704,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306121,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":1890,"price":72.34,"value":136722.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":146234,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306120,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":23110,"price":66.64,"value":1540050.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":144344,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":307092,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-07-16T20:54:41.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":129.9192,"value":389757.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":121234,"source":{"system":"sec-edgar","filing":"0001782135-26-000026","document":"wk-form4_1784235279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000026/wk-form4_1784235279.xml","form_type":"4"}},{"id":308227,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":450,"price":125.4,"value":56430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":124234,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308226,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1070,"price":123.9958,"value":132675.506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":124684,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308225,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1480,"price":123.4166,"value":182656.568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":125754,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308344,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27851,"derivative":{"underlying":"Common Stock","underlying_shares":2796},"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":308343,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":121.48,"value":162904.68,"ownership":{"direct":true},"balance_after":127234,"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":308342,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":128575,"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":759323,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restriced Stock Unit","published_at":"2026-05-29T22:04:22.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."}],"balance_after":2567,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2567},"source":{"system":"sec-edgar","filing":"0001782135-26-000020","document":"wk-form4_1780092260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000178213526000020/wk-form4_1780092260.xml","form_type":"4"}},{"id":768847,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T23:21:27.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0001782135-26-000018","document":"wk-form4_1779405685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000178213526000018/wk-form4_1779405685.xml","form_type":"4"}},{"id":768846,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T23:21:27.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6853,"source":{"system":"sec-edgar","filing":"0001782135-26-000018","document":"wk-form4_1779405685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000178213526000018/wk-form4_1779405685.xml","form_type":"4"}},{"id":309473,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":23110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309472,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":700,"price":132.7514,"value":92925.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices for the transactions reported range from $132.74 to $132.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":125779,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309471,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":8374,"price":132.2324,"value":1107314.1176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $131.71 to $132.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":126479,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309470,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":11177,"price":131.1917,"value":1466329.6309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $130.67 to $131.505. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":134853,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309469,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":7749,"price":130.2915,"value":1009628.8335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.66 to $130.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":146030,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309468,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":66.64,"value":1666000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":153779,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":310653,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-04-16T22:40:11.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":140.96,"value":422880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":128779,"source":{"system":"sec-edgar","filing":"0001782135-26-000014","document":"wk-form4_1776379208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000014/wk-form4_1776379208.xml","form_type":"4"}},{"id":311514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-03-17T22:56:30.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":144.23,"value":432690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":131779,"source":{"system":"sec-edgar","filing":"0001782135-26-000012","document":"wk-form4_1773788187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000012/wk-form4_1773788187.xml","form_type":"4"}},{"id":311728,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-03-12T20:42:04.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":35880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":35880,"derivative":{"exercise_price":148.56,"expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":35880},"source":{"system":"sec-edgar","filing":"0001782135-26-000010","document":"wk-form4_1773348121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000010/wk-form4_1773348121.xml","form_type":"4"}},{"id":311727,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:42:04.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":9590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":30647,"derivative":{"underlying":"Common Stock","underlying_shares":9590},"source":{"system":"sec-edgar","filing":"0001782135-26-000010","document":"wk-form4_1773348121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000010/wk-form4_1773348121.xml","form_type":"4"}},{"id":311726,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:42:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6617,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":21057,"derivative":{"underlying":"Common Stock","underlying_shares":6617},"source":{"system":"sec-edgar","filing":"0001782135-26-000010","document":"wk-form4_1773348121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000010/wk-form4_1773348121.xml","form_type":"4"}},{"id":311725,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:42:04.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3216,"price":148.56,"value":477768.96,"ownership":{"direct":true},"balance_after":134779,"source":{"system":"sec-edgar","filing":"0001782135-26-000010","document":"wk-form4_1773348121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000010/wk-form4_1773348121.xml","form_type":"4"}},{"id":311724,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:42:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6617,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":137995,"source":{"system":"sec-edgar","filing":"0001782135-26-000010","document":"wk-form4_1773348121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000010/wk-form4_1773348121.xml","form_type":"4"}},{"id":312381,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:54:14.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":11090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":131378,"source":{"system":"sec-edgar","filing":"0001782135-26-000008","document":"wk-form4_1772488451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000008/wk-form4_1772488451.xml","form_type":"4"}},{"id":313244,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-02-18T22:22:54.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":48110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001782135-26-000006","document":"wk-form4_1771453372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000006/wk-form4_1771453372.xml","form_type":"4"}},{"id":313243,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:22:54.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":200,"price":155.62,"value":31124.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":120288,"source":{"system":"sec-edgar","filing":"0001782135-26-000006","document":"wk-form4_1771453372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000006/wk-form4_1771453372.xml","form_type":"4"}},{"id":313242,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:22:54.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":9395,"price":154.9105,"value":1455384.1475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $154.57 to $155.27 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":120488,"source":{"system":"sec-edgar","filing":"0001782135-26-000006","document":"wk-form4_1771453372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000006/wk-form4_1771453372.xml","form_type":"4"}},{"id":313241,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:22:54.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":18405,"price":154.182,"value":2837719.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":129883,"source":{"system":"sec-edgar","filing":"0001782135-26-000006","document":"wk-form4_1771453372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000006/wk-form4_1771453372.xml","form_type":"4"}},{"id":313240,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:22:54.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":66.64,"value":1666000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":148288,"source":{"system":"sec-edgar","filing":"0001782135-26-000006","document":"wk-form4_1771453372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000006/wk-form4_1771453372.xml","form_type":"4"}},{"id":314332,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:51:29.000Z","date":"2026-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24800,"price":143.28,"value":3553344.0,"ownership":{"direct":true},"balance_after":123288,"source":{"system":"sec-edgar","filing":"0001782135-26-000004","document":"wk-form4_1770335486.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000004/wk-form4_1770335486.xml","form_type":"4"}},{"id":314331,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:51:29.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":44867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":148088,"source":{"system":"sec-edgar","filing":"0001782135-26-000004","document":"wk-form4_1770335486.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000004/wk-form4_1770335486.xml","form_type":"4"}},{"id":315234,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-16T23:10:36.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":124.31,"value":372930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":103221,"source":{"system":"sec-edgar","filing":"0001782135-26-000002","document":"wk-form4_1768605033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000002/wk-form4_1768605033.xml","form_type":"4"}},{"id":316067,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:12:40.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":122,"value":366000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":106221,"source":{"system":"sec-edgar","filing":"0001782135-25-000017","document":"wk-form4_1765926757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000017/wk-form4_1765926757.xml","form_type":"4"}},{"id":316247,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-11T23:25:33.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":3842,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27674,"derivative":{"underlying":"Common Stock","underlying_shares":3842},"source":{"system":"sec-edgar","filing":"0001782135-25-000015","document":"wk-form4_1765495531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000015/wk-form4_1765495531.xml","form_type":"4"}},{"id":316246,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T23:25:33.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1814,"price":121.34,"value":220110.76,"ownership":{"direct":true},"balance_after":109221,"source":{"system":"sec-edgar","filing":"0001782135-25-000015","document":"wk-form4_1765495531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000015/wk-form4_1765495531.xml","form_type":"4"}},{"id":316245,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T23:25:33.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":true,"shares":3842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":111035,"source":{"system":"sec-edgar","filing":"0001782135-25-000015","document":"wk-form4_1765495531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000015/wk-form4_1765495531.xml","form_type":"4"}},{"id":316957,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-11-18T23:51:51.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":73110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001782135-25-000013","document":"wk-form4_1763509908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000013/wk-form4_1763509908.xml","form_type":"4"}},{"id":316956,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-18T23:51:51.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":2476,"price":126.2575,"value":312613.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices for the transactions reported here range from $126.23 to $126.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC,\nthe issuer or its shareowners upon request."}],"balance_after":107193,"source":{"system":"sec-edgar","filing":"0001782135-25-000013","document":"wk-form4_1763509908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000013/wk-form4_1763509908.xml","form_type":"4"}},{"id":316955,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-18T23:51:51.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":25524,"price":125.8251,"value":3211559.8524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices for the transactions reported here range from $125.23 to $126.20. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC,\nthe issuer or its shareowners upon request."}],"balance_after":109669,"source":{"system":"sec-edgar","filing":"0001782135-25-000013","document":"wk-form4_1763509908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000013/wk-form4_1763509908.xml","form_type":"4"}},{"id":316954,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-18T23:51:51.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":66.64,"value":1666000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":135193,"source":{"system":"sec-edgar","filing":"0001782135-25-000013","document":"wk-form4_1763509908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000013/wk-form4_1763509908.xml","form_type":"4"}},{"id":317937,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-17T01:28:28.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":118.08,"value":354240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":110193,"source":{"system":"sec-edgar","filing":"0001782135-25-000011","document":"wk-form4_1760664505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000011/wk-form4_1760664505.xml","form_type":"4"}},{"id":318824,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-16T21:16:01.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":113.57,"value":340710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":113193,"source":{"system":"sec-edgar","filing":"0001782135-25-000008","document":"wk-form4_1758057358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000008/wk-form4_1758057358.xml","form_type":"4"}},{"id":318904,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T22:31:57.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":3844,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":31516,"derivative":{"underlying":"Common Stock","underlying_shares":3844},"source":{"system":"sec-edgar","filing":"0001782135-25-000004","document":"wk-form4_1757629914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000004/wk-form4_1757629914.xml","form_type":"4"}},{"id":318903,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:31:57.000Z","date":"2025-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1819,"price":115.25,"value":209639.75,"ownership":{"direct":true},"balance_after":116193,"source":{"system":"sec-edgar","filing":"0001782135-25-000004","document":"wk-form4_1757629914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000004/wk-form4_1757629914.xml","form_type":"4"}},{"id":318902,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:31:57.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":3844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":118012,"source":{"system":"sec-edgar","filing":"0001782135-25-000004","document":"wk-form4_1757629914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213525000004/wk-form4_1757629914.xml","form_type":"4"}},{"id":319760,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":98110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319759,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":false,"shares":11800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":98810,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":11800},"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319758,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":110610,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319757,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":false,"shares":11800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":111310,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":11800},"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319756,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":118.965,"value":23793.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sales prices for the transactions reported here range from $118.95 to $118.98.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":114168,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319755,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":118.5074,"value":331820.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices for the transactions reported here range from $117.91 to $118.85.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":114368,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319754,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":700,"price":118.9686,"value":83278.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices for the transactions reported here range from $118.91 to $119.01.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request."}],"balance_after":117168,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319753,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":true,"shares":700,"price":66.64,"value":46648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":117868,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319752,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":11800,"price":118.5089,"value":1398405.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices for the transactions reported here range from $117.91 to $118.89.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":117168,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319751,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":true,"shares":11800,"price":66.64,"value":786352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":128968,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319750,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":700,"price":118.9686,"value":83278.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices for the transactions reported here range from $118.91 to $119.01.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request."}],"balance_after":117168,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319749,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":true,"shares":700,"price":66.64,"value":46648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":117868,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319748,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":11800,"price":118.5044,"value":1398351.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices for the transactions reported here range from $117.91 to $118.89.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":117168,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":319747,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:56:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":true,"shares":11800,"price":66.64,"value":786352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":128968,"source":{"system":"sec-edgar","filing":"0000882095-25-000037","document":"wk-form4_1755564959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000037/wk-form4_1755564959.xml","form_type":"4"}},{"id":320685,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-07-16T21:45:01.000Z","date":"2025-07-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":111.03,"value":333090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":117168,"source":{"system":"sec-edgar","filing":"0001127602-25-019291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019291/form4.xml","form_type":"4"}},{"id":321405,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-17T22:04:57.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":110.17,"value":330510.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":120168,"source":{"system":"sec-edgar","filing":"0001127602-25-017689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017689/form4.xml","form_type":"4"}},{"id":321521,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-11T22:58:38.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3843,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":35360,"derivative":{"underlying":"Common Stock","underlying_shares":3843},"source":{"system":"sec-edgar","filing":"0001127602-25-017335","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017335/form4.xml","form_type":"4"}},{"id":321520,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:58:38.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1827,"price":110.09,"value":201134.43,"ownership":{"direct":true},"balance_after":123168,"source":{"system":"sec-edgar","filing":"0001127602-25-017335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017335/form4.xml","form_type":"4"}},{"id":321519,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:58:38.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3843,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":124995,"source":{"system":"sec-edgar","filing":"0001127602-25-017335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017335/form4.xml","form_type":"4"}},{"id":321894,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"exercise","planned":true,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":123110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321893,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"exercise","planned":true,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":135610,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321892,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":107.5212,"value":322563.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $107.16 to $107.87.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":121152,"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321891,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"sale","planned":true,"acquired":false,"shares":12500,"price":107.5231,"value":1344038.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $106.96 to $107.95.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":124152,"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321890,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"exercise","planned":true,"acquired":true,"shares":12500,"price":66.64,"value":833000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":136652,"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321889,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"sale","planned":true,"acquired":false,"shares":12500,"price":107.5169,"value":1343961.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $107.06 to $107.95.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":124152,"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":321888,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T19:16:26.000Z","date":"2025-05-22","kind":"exercise","planned":true,"acquired":true,"shares":12500,"price":66.64,"value":833000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":136652,"source":{"system":"sec-edgar","filing":"0001127602-25-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225015457/form4.xml","form_type":"4"}},{"id":1138126,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:12:04.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1435},"source":{"system":"sec-edgar","filing":"0000914475-25-000125","document":"wk-form4_1747948314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000125/wk-form4_1747948314.xml","form_type":"4"}},{"id":1138125,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:12:04.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."}],"balance_after":3318,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0000914475-25-000125","document":"wk-form4_1747948314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000125/wk-form4_1747948314.xml","form_type":"4"}},{"id":1138124,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:12:04.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3535,"source":{"system":"sec-edgar","filing":"0000914475-25-000125","document":"wk-form4_1747948314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000125/wk-form4_1747948314.xml","form_type":"4"}},{"id":324053,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T23:15:58.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":11090,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":39203,"derivative":{"underlying":"Common Stock","underlying_shares":11090},"source":{"system":"sec-edgar","filing":"0001127602-25-009295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009295/form4.xml","form_type":"4"}},{"id":324052,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T23:15:58.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":49020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":49020,"derivative":{"exercise_price":117.21,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":49020},"source":{"system":"sec-edgar","filing":"0001127602-25-009295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009295/form4.xml","form_type":"4"}},{"id":324051,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T23:15:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":8080,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":28113,"derivative":{"underlying":"Common Stock","underlying_shares":8080},"source":{"system":"sec-edgar","filing":"0001127602-25-009295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009295/form4.xml","form_type":"4"}},{"id":324050,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T23:15:58.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3907,"price":117.21,"value":457939.47,"ownership":{"direct":true},"balance_after":124152,"source":{"system":"sec-edgar","filing":"0001127602-25-009295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009295/form4.xml","form_type":"4"}},{"id":324049,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T23:15:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":8080,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":128059,"source":{"system":"sec-edgar","filing":"0001127602-25-009295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009295/form4.xml","form_type":"4"}},{"id":326500,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:14:11.000Z","date":"2025-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":45666,"price":97.99,"value":4474811.34,"ownership":{"direct":true},"balance_after":119979,"source":{"system":"sec-edgar","filing":"0001127602-25-003370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003370/form4.xml","form_type":"4"}},{"id":326499,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:14:11.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":70712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2022. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":165645,"source":{"system":"sec-edgar","filing":"0001127602-25-003370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003370/form4.xml","form_type":"4"}},{"id":326498,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:14:11.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":19793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":94933,"source":{"system":"sec-edgar","filing":"0001127602-25-003370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003370/form4.xml","form_type":"4"}},{"id":328476,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-12T00:08:25.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":3752,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":36193,"derivative":{"underlying":"Common Stock","underlying_shares":3752},"source":{"system":"sec-edgar","filing":"0001127602-24-029167","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029167/form4.xml","form_type":"4"}},{"id":328475,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:08:25.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1739,"price":92.34,"value":160579.26,"ownership":{"direct":true},"balance_after":75140,"source":{"system":"sec-edgar","filing":"0001127602-24-029167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029167/form4.xml","form_type":"4"}},{"id":328474,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:08:25.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":3752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":76879,"source":{"system":"sec-edgar","filing":"0001127602-24-029167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029167/form4.xml","form_type":"4"}},{"id":329605,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:38:35.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":91.28,"value":456400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on April 30, 2024."}],"balance_after":73127,"source":{"system":"sec-edgar","filing":"0001127602-24-026737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026737/form4.xml","form_type":"4"}},{"id":330776,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T21:08:41.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":13432,"price":83.25,"value":1118214.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on April 30, 2024."}],"balance_after":78127,"source":{"system":"sec-edgar","filing":"0001127602-24-023932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023932/form4.xml","form_type":"4"}},{"id":330775,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T21:08:41.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":15925,"price":84.23,"value":1341362.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on April 30, 2024."}],"balance_after":91559,"source":{"system":"sec-edgar","filing":"0001127602-24-023932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023932/form4.xml","form_type":"4"}}],"next_cursor":"2024-09-13T21:08:41.000000Z,330775"}